Skip to content

The effects of aerobic- versus resistance-based exercise on breast cancer-related lymphoedema

Measuring the effects of aerobic- versus resistance-based exercise on lymphoedema status in primary breast cancer survivors with breast cancer-related lymphoedema

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000665730
Enrollment
48
Registered
2013-06-19
Start date
2013-05-20
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study is evaluating and comparing the effects of aerobic-based versus resistance-based exercise to usual care on lymphoedema, lymphoedema-related symptoms (e.g. decreased fitness, impaired functioning, changes in weight, strength loss), and quality of life. Who is it for? You may be eligible to join this study if you are a female, aged 18 years to 70 years, with a diagnosis of unilateral breast cancer-related lymphoedema following nonmetastatic breast cancer, completed all cancer-related treatments, and physically capable of participating in a moderate-intensity exercise program. Trial details Participants in this study will be randomly (by chance) divided into one of three groups. Participants in one group will be allocated to a 12 week aerobic-based exercise intervention. Participants in the second group will be allocated to a 12-week resistance-based exercise intervention. Participants in the third group will be allocated to usual care, which will involves a weekly phone call to monitor physical activity levels and lymphoedema symptoms and treatment, as well as to maintain study interest. Following the 24-week intervention, this group will be offered a personalised exercise program. All participants, regardless of group allocation, will be assessed pre- and post-intervention and again at 12 weeks post-intervention. Participants will be required to complete some questionnaires and tests throughout the duration of the trial in order to evaluate the effects of aerobic-based exercise and resistance-based exercise on fitness level, weight changes, strength, function, self-efficacy, presence of lymphoedema and quality of life. The results of this trial will help gain a better understanding on whether participating in certain exercise types provides greater lymphoedema-related benefits over other types or usual care.

Interventions

This study will evaluate and compare the effects of aerobic- versus resistance-based exercise to usual care on lymphoedema, lymphoedema-related symptoms (e.g. decreased fitness, impaired functioning, changes in weight, strength loss), and quality of life. Women will be asked to participate in a 12-week intervention (or usual care) and will be assessed pre- and post-intervention and 12 weeks post-intervention. For those in the aerobic-based exercise group, any form of aerobic activity may be

This study will evaluate and compare the effects of aerobic- versus resistance-based exercise to usual care on lymphoedema, lymphoedema-related symptoms (e.g. decreased fitness, impaired functioning, changes in weight, strength loss), and quality of life. Women will be asked to participate in a 12-week intervention (or usual care) and will be assessed pre- and post-intervention and 12 weeks post-intervention. For those in the aerobic-based exercise group, any form of aerobic activity may be undertaken, provided it is at a Rating of Perceived Exertion (RPE) of 11-13 (on a 6-20 scale) for weeks 1-6 and an RPE of 12-14 for weeks 7-12. Sessions will be conducted at location convenient to the participant. During weeks 1-4, there will be 2 supervised sessions a week (50 minutes each), with participants asked to accumulate another 50 minutes of unsupervised exercise (150 minutes total each week). For weeks 5-12, participants will receive 1 supervised session per week (50 minutes) and be asked to achieve an additional 100 minutes unsupervised. All resistance-based exercise sessions will begin with a five-minute cardiovascular warm-up period, followed by a full-body strength training program, including: chest fly, triceps kick-back, squat, curl-ups, bent-over row, bridging, wall push-up, bicep curls, calf raises, shoulder press, external rotation and forward lunge. Modifications will be made at the research’s discretion if pain, injury or altered range of motion prevents proper technique of the given exercise. The same schedule and intensity as the aerobic-based group will be used in the resistance-based group. To monitor adherence, participants in the aerobic- and resistance-based exercise groups will be given activity logs in which to record their weekly, unsupervised exercise, including time, modality and RPE during the session. They will also be asked to record relevant information for exercise sessions (e.g., modifications, pain/discomfort, barriers encountered). At each supervised session over the 12-week intervention, the researcher will review this log with the participant to assess adherence and address any concerns or queries that may arise. The researcher and participant will also schedule days and times during the week when the unsupervised exercise will be undertaken, with identification of an additional ‘back-up’ time period should any barriers arise during any of the selected times. As each program is supervised, this will include discussion of personal barriers and strategies to overcome them, as is traditionally done by exercise physiologists. Verbal praise will be used when participants complete expected unsupervised exercise and given positive encouragement and advice when unsuccessful in meeting the weekly goal. Though 100% adherence is emphasised, individuals will be reminded that an overall adherence of 80%, or 1920 total minutes, over the 12 weeks is the ultimate aim, and if there are weeks they cannot obtain 150 minutes of exercise, they can make up the missed time the following week. Participants in the usual care control group will be called weekly (weeks 1-4) or fortnightly (weeks 5-12) to maintain their interest in the study and ensure they have not increased their exercise participation.

Sponsors

Jena Buchan
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Women with a diagnosis of unilateral breast cancer-related lymphoedema following nonmetastatic breast cancer, completed all cancer-related treatments, physically capable of participating in a moderate-intensity exercise program

Exclusion criteria

unable to read and understand English; pregnant or may become pregnant during intervention; ECOG status of 3+; women with a cognitive impairment or mental illness; currently undertaking more than half of the exercise prescription (i.e. 75 minutes/week of moderate-intensity exercise)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026